For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...

In Virginia, health statistics show more than 20,000 people depend on dialysis and just a few thousand fewer have had kidney transplants. Chronic Kidney Disease impacts countless people, especially in ...

By the time you graduate medical school, you should have a handle on these chronic diseases, as you’ll likely encounter them ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

Kidney failure affects millions worldwide, and the number keeps rising. Each year, the global population of patients with end ...

Anyone who has diabetes, high blood pressure, heart problems or has a family history of the disease is at increased risk for ...

Black Americans face four times higher risk of kidney disease, with thousands undiagnosed due to healthcare gaps. Experts ...

CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and hyperphosphatemiaFinal European Commission decision ...

More than 1 in 7 adults are estimated to have chronic kidney disease, which is a progressive decrease in kidney function. As many as 9 in 10 of them don’t know they have it.